Long-term prognosis of patients with frequently-relapsing / steroid-dependent nephrotic syndrome who participated in JSKDC10 clinical trials

Long-term prognosis of patients with frequently-relapsing / steroid-dependent nephrotic syndrome who participated in JSKDC10 clinical trials - Long-term prognosis of JSKDC10 clinical trials

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050230024

Enrollment

Registered

2023-05-21

Start date

2023-05-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frequently-relapsing/ steroid-dependent nephrotic syndrome nephrotic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with frequently-relapsing/steroid-dependent nephrotic syndrome who participated in the JSKDC 10 clinical traials

Exclusion criteria

Exclusion criteria: Patients who were offered non-participation in this study from publicly available information

Design outcomes

Primary

Measure	Time frame
Relapse-free period	—

Secondary

Measure	Time frame
(1) Relapse (2) Relapse rate (times/person-year) (3) Progression to frequently-relapsing/steroid-dependent or steroid-resistant nephrotic syndrome (4) Treatment with or without additional immunosuppressants or rituximab (5) Serum IgG level	—

Contacts

Public ContactTomoko Horinouchi

Kobe University

tohori@med.kobe-u.ac.jp+81-78-382-6090

Outcome results